Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 17, 2023

BUY
$39.39 - $51.28 $468,504 - $609,924
11,894 Added 42.67%
39,770 $1.62 Million
Q4 2022

Jan 25, 2023

BUY
$41.75 - $54.5 $692,173 - $903,555
16,579 Added 146.76%
27,876 $0
Q3 2022

Oct 12, 2022

BUY
$43.76 - $53.42 $206,503 - $252,088
4,719 Added 71.74%
11,297 $494,000
Q2 2022

Jul 11, 2022

BUY
$46.53 - $55.17 $3,815 - $4,523
82 Added 1.26%
6,578 $345,000
Q1 2022

Apr 14, 2022

BUY
$45.75 - $56.69 $45 - $56
1 Added 0.02%
6,496 $336,000
Q4 2021

Feb 02, 2022

BUY
$41.32 - $61.25 $268,373 - $397,818
6,495 New
6,495 $384,000
Q1 2021

Apr 14, 2021

SELL
$33.49 - $37.77 $219,694 - $247,771
-6,560 Closed
0 $0
Q4 2020

Feb 02, 2021

SELL
$33.47 - $42.56 $9,605 - $12,214
-287 Reduced 4.19%
6,560 $241,000
Q3 2020

Nov 12, 2020

SELL
$31.75 - $37.25 $57,118 - $67,012
-1,799 Reduced 20.81%
6,847 $251,000
Q2 2020

Sep 29, 2020

SELL
$30.12 - $36.54 $32,740 - $39,718
-1,087 Reduced 11.17%
8,646 $283,000
Q1 2020

May 15, 2020

SELL
$27.03 - $38.62 $3,459 - $4,943
-128 Reduced 1.3%
9,733 $318,000
Q4 2019

Jan 09, 2020

SELL
$32.92 - $37.36 $44,014 - $49,950
-1,337 Reduced 11.94%
9,861 $384,000
Q3 2019

Oct 24, 2019

SELL
$32.49 - $42.13 $234,252 - $303,757
-7,210 Reduced 39.17%
11,198 $402,000
Q2 2019

Aug 08, 2019

SELL
$36.98 - $41.52 $5,399 - $6,061
-146 Reduced 0.79%
18,408 $797,000
Q1 2019

May 15, 2019

BUY
$37.5 - $41.2 $695,775 - $764,424
18,554 New
18,554 $793,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $167B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Rba Wealth Management, LLC Portfolio

Follow Rba Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rba Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rba Wealth Management, LLC with notifications on news.